Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey

Roodenrijs, N. M.T. et al. (2018) Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey. Annals of the Rheumatic Diseases, 77(12), pp. 1705-1709. (doi: 10.1136/annrheumdis-2018-213687) (PMID:30194273)

[img]
Preview
Text
169174.pdf - Accepted Version

187kB

Abstract

Objectives: Patients with difficult-to-treat rheumatoid arthritis (RA) remain symptomatic despite treatment according to current European League Against Rheumatism (EULAR) management recommendations. These focus on early phases of the disease and pharmacological management. We aimed to identify characteristics of difficult-to-treat RA and issues to be addressed in its workup and management that are not covered by current management recommendations. Methods: An international survey was conducted among rheumatologists with multiple-choice questions on disease characteristics of difficult-to-treat RA. Using open questions, additional items to be addressed and items missing in current management recommendations were identified. Results: 410 respondents completed the survey: 50% selected disease activity score assessing 28 joints >3.2 OR presence of signs suggestive of active disease as characteristics of difficult-to-treat RA; 42% selected fatigue; 48% selected failure to ≥2 conventional synthetic disease-modifying antirheumatic drugs (DMARDs) AND ≥2 biological/targeted synthetic DMARDs; 89% selected inability to taper glucocorticoids below 5 mg or 10 mg prednisone equivalent daily. Interfering comorbidities, extra-articular manifestations and polypharmacy were identified as important issues missing in current management recommendations. Conclusions: There is wide variation in concepts of difficult-to-treat RA. Several important issues regarding these patients are not addressed by current EULAR recommendations.

Item Type:Articles
Keywords:Clinical and epidemiological research, 2311, rheumatoid arthritis, disease activity, treatment.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McInnes, Professor Iain
Authors: Roodenrijs, N. M.T., de Hair, M. J.H., van der Goes, M. C., Jacobs, J. W.G., Welsing, P. M.J., van der Heijde, D., Aletaha, D., Dougados, M., Hyrich, K. L., McInnes, I. B., Mueller-Ladner, U., Senolt, L., Szekanecz, Z., van Laar, J. M., and Nagy, G.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Annals of the Rheumatic Diseases
Publisher:BMJ Publishing Group
ISSN:0003-4967
ISSN (Online):1468-2060
Published Online:07 September 2018
Copyright Holders:Copyright © 2018 The Authors
First Published:First published in Annals of the Rheumatic Diseases 77(12):1705-1709
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record